Shares of Teva Pharmaceutical Industries (NYSE: TEVA) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p.m.

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

US-based pharmaceutical company 60 Degrees Pharmaceuticals has received approval from the investigational review board (IRB) ...

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Patients might not know about Roche Tissue Diagnostics, but the Arizona entity has been testing for cancer and helping devise ...

Robert F. Kennedy, Jr. – the vaccine skeptic President Donald Trump has nominated to serve as Health and Human Services ...

The company has 11 world-class manufacturing ... For more information, visit www.glenmarkpharma.com. You can follow us on LinkedIn (Glenmark Pharmaceuticals) and Instagram (glenmark_pharma).

Indiana Attorney General Todd Rokita is suing two pharmaceutical companies over alleged anticompetitive acts regarding a life ...